Literature DB >> 26546297

Huge Data-Sharing Project Launched.

Suzanne Rose.   

Abstract

Aiming to advance precision medicine in oncology and improve patient care, the American Association for Cancer Research has launched an international initiative known as AACR Project Genomics, Evidence, Neoplasia, Information, Exchange (GENIE). The venture will pool existing and future next-generation clinical sequencing data with longitudinal clinical outcomes and related pathology reports from several institutions in the United States, Canada, and Europe, to find new mutations, assess potential biomarkers, and identify patient populations that might benefit from existing treatments. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2015        PMID: 26546297     DOI: 10.1158/2159-8290.CD-NB2015-159

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  7 in total

1.  Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.

Authors:  Todd C Knepper; Gillian C Bell; J Kevin Hicks; Eric Padron; Jamie K Teer; Teresa T Vo; Nancy K Gillis; Neil T Mason; Howard L McLeod; Christine M Walko
Journal:  Oncologist       Date:  2017-02-08

2.  Implementation and Clinical Utility of an Integrated Academic-Community Regional Molecular Tumor Board.

Authors:  Mark E Burkard; Dustin A Deming; Benjamin M Parsons; Paraic A Kenny; Marissa R Schuh; Ticiana Leal; Nataliya Uboha; Joshua M Lang; Michael A Thompson; Ruth Warren; Jordan Bauman; Mary S Mably; Jennifer Laffin; Catherine R Paschal; Angela M Lager; Kristy Lee; Kristina A Matkowskyj; Darya G Buehler; William M Rehrauer; Jill Kolesar
Journal:  JCO Precis Oncol       Date:  2017-07-05

3.  Somatic cancer variant curation and harmonization through consensus minimum variant level data.

Authors:  Deborah I Ritter; Sameek Roychowdhury; Angshumoy Roy; Shruti Rao; Melissa J Landrum; Dmitriy Sonkin; Mamatha Shekar; Caleb F Davis; Reece K Hart; Christine Micheel; Meredith Weaver; Eliezer M Van Allen; Donald W Parsons; Howard L McLeod; Michael S Watson; Sharon E Plon; Shashikant Kulkarni; Subha Madhavan
Journal:  Genome Med       Date:  2016-11-04       Impact factor: 11.117

4.  Multicenter fresh frozen tissue sampling in colorectal cancer: does the quality meet the standards for state of the art biomarker research?

Authors:  Z S Lalmahomed; R R J Coebergh van den Braak; M H A Oomen; S P Arshad; P H J Riegman; J N M IJzermans
Journal:  Cell Tissue Bank       Date:  2017-03-03       Impact factor: 1.522

Review 5.  Implementation and utilization of the molecular tumor board to guide precision medicine.

Authors:  Shuko Harada; Rebecca Arend; Qian Dai; Jessica A Levesque; Thomas S Winokur; Rongjun Guo; Martin J Heslin; Lisle Nabell; L Burt Nabors; Nita A Limdi; Kevin A Roth; Edward E Partridge; Gene P Siegal; Eddy S Yang
Journal:  Oncotarget       Date:  2017-06-14

6.  Targeting ERBB2 mutations in solid tumors: biological and clinical implications.

Authors:  Sophie Cousin; Emmanuel Khalifa; Amandine Crombe; Yech'an Laizet; Carlo Lucchesi; Maud Toulmonde; Sylvestre Le Moulec; Céline Auzanneau; Isabelle Soubeyran; Antoine Italiano
Journal:  J Hematol Oncol       Date:  2018-06-25       Impact factor: 17.388

7.  The cancer proteomic landscape and the HUPO Cancer Proteome Project.

Authors:  Connie R Jimenez; Hui Zhang; Christopher R Kinsinger; Edouard C Nice
Journal:  Clin Proteomics       Date:  2018-01-25       Impact factor: 3.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.